Panacea Biotec Limited — Important, 07-01-2025: Updates

No shares were dematerialized in December 2024. As of December 31, 2024, the total shares dematerialized were 61,089,525, comprising 52,711,055 in NSDL and 8,378,470 in CDSL. This stability in the dematerialization of shares suggests a consistent investor interest in Panacea Biotec's securities. The absence of new dematerializations could indicate a cautious sentiment among investors, which may be worth monitoring as it might affect the liquidity of the shares in the market. Investors should keep an eye on future developments that could influence trading activity and overall market confidence.